Drugs / Vuloven
Vuloven
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01192581 | Aug 2010 → Apr 2011 | cerebrovascular disorder | Xijing Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vuloven | “study drug (hydroxyethyl starch 130/0.4 and sodium chloride injection, Vuloven)” NCT01192581 ↗ |
| Known as | hydroxyethyl starch 130/0.4 and sodium chloride injection | “study drug (hydroxyethyl starch 130/0.4 and sodium chloride injection, Vuloven)” NCT01192581 ↗ |
| Route | Intravenous | “administrated intravenously for 7 days” NCT01192581 ↗ |